- Home
- HCM vs WRBY Comparison
HCM vs WRBY Comparison
Compare HCM & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | WRBY |
|---|---|---|
| Founded | 2000 | 2010 |
| Country | Hong Kong | United States |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HCM | WRBY |
|---|---|---|
| Price | $13.18 | $21.79 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $13.75 | ★ $27.10 |
| AVG Volume (30 Days) | 28.0K | ★ 1.9M |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 105.88 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $871,905,000.00 |
| Revenue This Year | $20.60 | $14.48 |
| Revenue Next Year | $15.62 | $16.41 |
| P/E Ratio | ★ $5.49 | $2,307.00 |
| Revenue Growth | N/A | ★ 13.04 |
| 52 Week Low | $12.82 | $14.96 |
| 52 Week High | $19.50 | $31.00 |
Technical Indicators
Market Signals| Indicator | HCM | WRBY |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 45.24 |
| Support Level | $13.08 | $20.97 |
| Resistance Level | $15.59 | $22.64 |
| Average True Range (ATR) | 0.44 | 1.43 |
| MACD | -0.21 | -0.11 |
| Stochastic Oscillator | 13.68 | 11.05 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.